Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Oncology"
DOI: 10.1002/1878-0261.12035
Abstract: Bladder carcinogenesis and tumour progression is accompanied by profound alterations in protein glycosylation on the cell surface, which may be explored for improving disease management. In a search for prognosis biomarkers and novel therapeutic targets… read more here.
Keywords: poor prognosis; bladder; bladder tumours; advanced stage ... See more keywords
Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008‐2015
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2018.07.025
Abstract: Introduction: Current real‐world data regarding treatment patterns in advanced bladder cancer in the community setting are limited. This study describes patient characteristics, treatment patterns, and effectiveness outcomes for stage IV bladder cancer in the community… read more here.
Keywords: bladder cancer; treatment; cancer; oncology ... See more keywords